![]() |
|
|
Forward to a colleague |
||
Access Full Stories The discoverer of embryonic stem cells (ES cells) and two other scientists have won a Nobel Prize for their work to develop a 'magic wand' to modify the mouse genome... Read UK innovation to get billion pound boost The UK government has set-aside £1bn (€1.45bn) to give early-stage companies better support after a review of the UK's science and innovation policies by Lord Sainsbury of Turville... Read Pharmaceuticals is top R&D spender As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development... Read Novartis osteoporosis drug gets EU nod Swiss pharma Novartis has had the two thumbs up from the EU for its once-yearly treatment for postmenopausal osteoporosis... Read Clinical staffing a 'tremendous problem' The European clinical trials industry is experiencing a "tremendous problem" with staff recruitment - salaries are climbing as a result... Read |
|||||||||||||||||
All News Headlines for: October | September | August |
|||||||||||||||||
Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here | |||||||||||||||||
|
Related Industry News Three more nailed in fake drugs scandal Three more individuals have been sentenced following last month's exposure of the largest counterfeit drugs conspiracy ever to be encountered in the UK... Read FDA generics initiative waste of money? The Generic Pharmaceutical Association has questioned a new US Food and Drug Administration (FDA) initiative as possibly "throwing money down the drain"... Read Excipients unregulated and unacceptable The European Fine Chemicals Group (EFCG) has called for stricter regulation of pharmaceutical excipients in a bid to prevent substandard and potentially dangerous products ending up in medicinal drugs... Read Novo to sell off its NNE engineering unit Denmark's Novo Nordisk, could be on the verge of selling off its engineering division, if reports in the local business daily Borsen are to be believed... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||